Vitamin A and Alzheimer's disease (Q22242414)

PubMed

PubMed publication ID

22221326

8 February 2023

Masahito Yamada

series ordinal

2

author given names

Masahito

author last names

Yamada

1 reference

PubMed

PubMed publication ID

22221326

Geriatrics and Gerontology International

8 February 2023

language of work or name

English

0 references

publication date

23 December 2011

0 references

published in

0 references

volume

12

0 references

issue

2

0 references

page(s)

180-188

0 references

cites work

Therapies for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The Development of New Therapeutics for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Substrate-targeting gamma-secretase modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Hot spots of retinoic acid synthesis in the developing spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The relation between antioxidants and memory performance in the old and very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Presenile dementia and Alzheimer's disease in mongolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Low-n oligomers as therapeutic targets of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Oxidants, oxidative stress and the biology of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Kinetic theory of fibrillogenesis of amyloid β-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Structure-neurotoxicity relationships of amyloid beta-protein oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Prion protein and Abeta-related synaptic toxicity impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Vitamin E and beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippocampal culture model of fetal alcohol syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

The antioxidants vitamin E and beta-carotene protect against ethanol-induced neurotoxicity in embryonic rat hippocampal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Retinoic acid isomers protect hippocampal neurons from amyloid-beta induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Vitamin A deficiency produces spatial learning and memory impairment in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Evidence for defective retinoid transport and function in late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Retinoic acid is detected at relatively high levels in the CNS of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

Solubility of retinoids in water

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Adult rabbit brain synthesizes retinoic acid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

Vitamin A has anti-oligomerization effects on amyloid-β in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00786.X

7 January 2021

10.1111/J.1447-0594.2011.00786.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22221326

1 reference

Consolidated OpenCitations Corpus – April 2017